New Liver Cancer Study Results Reported from University of Ulsan (Regorafenib Plus Nivolumab In Unresectable Hepatocellular Carcinoma: the Phase 2 Renobate Trial)

Press/Media

Period10 Apr 2024

Media coverage

1

Media coverage

  • TitleNew Liver Cancer Study Results Reported from University of Ulsan (Regorafenib Plus Nivolumab In Unresectable Hepatocellular Carcinoma: the Phase 2 Renobate Trial)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date10/04/24
    PersonsSeok Lee
View all 1
View less